Immunocore Holdings plc (IMCR) — Financial statements
Income statement, balance sheet, and cash flow for Immunocore Holdings plc — annual and quarterly history with growth and margin analysis.
| Metric (USD Millions) | 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|---|
| Revenue & Gross Profit | ||||||
| Revenue | 298↑20.0% | 248↑25.6% | 197↑36.9% | 144↑433.3% | 27 | |
| Cost of Revenue | 6↑12.1% | 6↑575.6% | 0.82↓84.5% | 5 | 0.00 | |
| Gross Profit | 291↑20.2% | 242↑23.3% | 197↑41.5% | 139↑413.7% | 27 | |
| Operating Expenses | ||||||
| R&D Expenses | 204↑15.2% | 177↑37.1% | 129↑53.5% | 84↑13.5% | 74 | |
| General & Administrative Expenses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Selling & Marketing Expenses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| SG&A Expenses | 121↓0.5% | 121↑6.0% | 114 | 0.00↓100.0% | 82 | |
| Other Expenses | 0.00 | 0.00 | 0.00↓100.0% | 97 | 0.00 | |
| Operating Expenses | 325↑8.8% | 299↑22.6% | 244↑34.1% | 182↑16.1% | 156 | |
| Total Costs & Expenses | 331↑8.9% | 304↑24.4% | 245↑30.8% | 187↑19.5% | 156 | |
| Operating Results | ||||||
| Operating Income | -34↑40.1% | -56↓19.2% | -47↓10.4% | -43↑66.9% | -129 | |
| Depreciation & Amortization | 2↓27.6% | 3↑3.7% | 3↓26.7% | 4↓21.6% | 6 | |
| EBITDA | 0.39↑101.0% | -39↑5.8% | -41↓6.6% | -38↑69.0% | -124 | |
| EBIT | -2↑95.1% | -42↑5.1% | -44↓3.1% | -43↑66.9% | -129 | |
| Interest & Other Income | ||||||
| Net Interest Income | 4↓36.4% | 7↓33.3% | 10↑714.3% | -2↑70.0% | -6 | |
| Interest Income | 16↓35.7% | 26↑80.0% | 14↑278.9% | 4↑5678.5% | 0.07 | |
| Interest Expense | 12↓35.4% | 19↑362.0% | 4↓24.6% | 5↓2.9% | 6 | |
| Non-Operating Income | -32↓119.8% | -14↓365.6% | -3↓53381.3% | -0.01↑97.2% | -0.21 | |
| Other Income / Expenses | 20↑39.4% | 14↑1526.5% | -0.98↓111.0% | 9↑328.3% | -4 | |
| Income Before Tax | -14↑66.4% | -42↑12.2% | -48↓42.5% | -34↑74.6% | -133 | |
| Income Tax Expense | 12↑925.6% | -1↑66.6% | -4↓146.0% | 10↑8574.6% | 0.11 | |
| Net Income & EPS | ||||||
| Net Income from Continuing Operations | -26↑35.3% | -41↑6.7% | -44↓0.7% | -43↑67.4% | -133 | |
| Net Income from Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Net Income | -26↑35.3% | -41↑6.7% | -44↓0.7% | -43↑67.4% | -133 | |
| Bottom-Line Net Income | -26↑35.3% | -41↑6.7% | -44↓0.7% | -43↑67.4% | -133 | |
| EPS (Basic) | -0.53↑48.0% | -1.02↓14.6% | -0.89↑6.3% | -0.95↑69.6% | -3.13 | |
| EPS (Diluted) | -0.53↑48.0% | -1.02↓14.6% | -0.89↑6.3% | -0.95↑68.3% | -3.00 | |
| Weighted Average Shares | 50↑0.7% | 50↑2.3% | 49↑6.9% | 46↑7.6% | 42 | |
| Weighted Average Diluted Shares | 50↑0.7% | 50↑2.3% | 49↑6.9% | 46↑4.2% | 44 | |
* All figures in Millions of USD, except per share data. Growth rates calculated Year-over-Year (YoY). Data source: SEC Filings.